Perek D, Dembowska-Bagińska B, Jurczyk-Procyk S, Zelazowski J
Klinika Onkologii Dzieci i Młodziezy Instytutu Matki i Dziecka w Warszawie.
Pediatr Pol. 1996 Aug;71(8):659-65.
A retrospective analysis of treatment results of 242 children with Wilms tumor treated in the years 1962-1989 is presented. The patients (pts) were divided into 4 groups according to methods of treatment that changed with the time. Group I consisted of patients treated between 1962-1965. Surgery followed by radiotherapy (RTX) and monochemotherapy (CHT) (ACTD) were the main treatment methods. Group II consisted of 68 patients treated between 1966-1974. In this group, surgery was followed by RTX and CHT (multiple courses of ACTD + VCR). Group III included 68 patients treated between 1975-1982. Preoperative RTX (20 Gy) and CHT (ACTD) were administered. RTX (total 35 Gy) and adjuvant CHT were continued after surgery. Group IV consisted of 62 patients treated in 1982-1989. Preoperative CHT (ACTD, VCR +/- ADR) was introduced. Adjuvant treatment depended on stage and histology of the tumor. The treatment results were as follows: 27, 66.1, 38.2 and 85.4% of survival, respectively. This points to the beneficial role of induction CHT, delayed surgery with adjusting the intensity of further adjuvant treatment to stage and tumor histology.
本文对1962年至1989年期间接受治疗的242例肾母细胞瘤患儿的治疗结果进行了回顾性分析。根据随时间变化的治疗方法,将患者分为4组。第一组包括1962年至1965年期间接受治疗的患者。主要治疗方法是手术,随后进行放疗(RTX)和单一化疗(CHT)(放线菌素D)。第二组包括68例在1966年至1974年期间接受治疗的患者。在该组中,手术之后是RTX和CHT(多疗程放线菌素D + 长春新碱)。第三组包括68例在1975年至1982年期间接受治疗的患者。术前给予RTX(20 Gy)和CHT(放线菌素D)。术后继续进行RTX(总计35 Gy)和辅助化疗。第四组由1982年至1989年期间接受治疗的62例患者组成。引入了术前CHT(放线菌素D、长春新碱 +/- 阿霉素)。辅助治疗取决于肿瘤的分期和组织学类型。治疗结果如下:生存率分别为27%、66.1%、38.2%和85.4%。这表明诱导化疗、延迟手术以及根据分期和肿瘤组织学调整进一步辅助治疗强度具有有益作用。